Intelligent Medicine Acquisition Corp.

NasdaqGM:IQMD Stock Report

Market Cap: US$64.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Intelligent Medicine Acquisition Valuation

Is IQMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IQMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IQMD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IQMD's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IQMD?

Key metric: As IQMD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IQMD. This is calculated by dividing IQMD's market cap by their current earnings.
What is IQMD's PE Ratio?
PE Ratio5.7x
EarningsUS$11.41m
Market CapUS$64.75m

Price to Earnings Ratio vs Peers

How does IQMD's PE Ratio compare to its peers?

The above table shows the PE ratio for IQMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average49.4x
HAIA Healthcare AI Acquisition
84.3xn/aUS$68.4m
KYCH Keyarch Acquisition
12xn/aUS$54.6m
NVAC NorthView Acquisition
n/an/aUS$68.9m
JAQC Jupiter Acquisition
52xn/aUS$62.2m
IQMD Intelligent Medicine Acquisition
5.7xn/aUS$64.8m

Price-To-Earnings vs Peers: IQMD is good value based on its Price-To-Earnings Ratio (5.7x) compared to the peer average (32.9x).


Price to Earnings Ratio vs Industry

How does IQMD's PE Ratio compare vs other companies in the US Capital Markets Industry?

23 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ADX Adams Diversified Equity Fund
3.6xn/aUS$2.29b
CET Central Securities
4.5xn/aUS$1.33b
GAM General American Investors Company
4.2xn/aUS$1.19b
MUDS Mudrick Capital Acquisition Corporation II
3.4xn/aUS$401.64m
IQMD 5.7xIndustry Avg. 23.2xNo. of Companies73PE020406080100+
23 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IQMD is good value based on its Price-To-Earnings Ratio (5.7x) compared to the US Capital Markets industry average (27.8x)


Price to Earnings Ratio vs Fair Ratio

What is IQMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IQMD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio5.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IQMD's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies